Stem Cell Research (Dec 2019)

Induced pluripotent stem cells (iPSCs) derived from a renpenning syndrome patient with c.459_462delAGAG mutation in PQBP1 (PEIi001-A)

  • Nina V. Fuchs,
  • Maximilian Schieck,
  • Michaela Neuenkirch,
  • Christiane Tondera,
  • Heike Schmitz,
  • Vincent des Portes,
  • David Germanaud,
  • Doris Steinemann,
  • Gudrun Göhring,
  • Renate König

Journal volume & issue
Vol. 41

Abstract

Read online

The Renpenning syndrome spectrum is a rare X-linked mental retardation syndrome characterized by intellectual disability, microcephaly, low stature, lean body and hypogonadism. Mutations in the polyglutamine tract binding protein 1 (PQBP1) locus are causative for disease. Here, we describe the generation of an iPSC line from a patient mutated in the polar amino acid-rich domain of PQBP1 resulting in a C-terminal truncated protein (c.459_462 delAGAG, type p.R153fs193X).